555 LONG WHARF DRIVE, NEW HAVEN, CT
Other Events
Financial Results, Press Release
BioXcel Therapeutics Enters Registered Direct Offering for 2.48M Shares
BioXcel Therapeutics Enters Milestone and Retention Bonus Agreements
Annual Meeting Results - Election of Directors at BioXcel Therapeutics
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload